Our observation that MDA-9/Syntenin overexpression was evident in pre-neoplastic stages supports a model in which MDA-9/Syntenin mediated down-regulation of SPRR1B is an early event preventing terminal differentiation thereby aiding in tumor progression. The gene discussed is SPRR1B; the disease is neoplasm.